Highlights From the San Antonio Breast Cancer Symposium 2020
My top three takeaways from the 2020 San Antonio Breast Cancer Symposium.
Category: Research Updates
New Treatments for Triple Negative Breast Cancer
This year we’ve seen some encouraging news with approvals of a targeted therapy and an immunotherapy for triple negative breast cancer.
Highlights From the San Antonio Breast Cancer Symposium 2019
Top “take-home” highlights from the 2019 San Antonio Breast Cancer Symposium.
Targeted Treatments for Hormone Receptor-Positive Breast Cancer
There were some noteworthy developments this year in targeted therapies for hormone receptor-positive breast cancer.
Breast Cancer Treatment: The TAILORx Clinical Trial
Findings from the TAILORx clinical trial will help personalize treatment decisions for many patients with early stage breast cancer.
5 Cancer Research Stories Worth Following – Spring 2018
Researchers are working on ways to make immune system therapies more effective for more cancer patients.
5 Cancer Research Stories Worth Following – Winter 2018
Cancer research stories worth following this winter included reports on new approaches to immunotherapy currently being tested in clinical trials.
5 Cancer Research Stories Worth Following – Fall 2017
Recent cancer research stories worth following include a study on post-traumatic stress disorder after a cancer diagnosis.
5 Cancer Research Stories Worth Following – Summer 2017
Two FDA approvals for immunotherapy treatments highlight cancer research news this summer. But the extremely high costs of new cancer therapies are yet to be addressed.
A Role for Progesterone in Breast Cancer Treatment?
New clinical trials will test whether the addition of progesterone could improve treatment for hormone receptor-positive breast cancer.
